I said in November 2020 when the aGVHD BLA submission resulted in a CRL that the only thing that would move the SP would be an approval, or a solid indication that an approval was imminent. Up to now, all of the data released has been positive and the company is still on the right track in my opinion, but the market needs to see clear steps towards commercialisation, not words, but actual approvals and sales. Ultimately the market, by and large, reads the value of the bottom line, not the value of the opportunity. Personally, I am still very bullish on the company's prospects. I'm not a financial advisor though, so do your own research.
I said in November 2020 when the aGVHD BLA submission resulted...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.010(0.92%) |
Mkt cap ! $1.233B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.11 | $1.05 | $5.002M | 4.632M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5697 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
-0.010 ( 0.10 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.11 | $1.06 | 1181223 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| MSB (ASX) Chart |